ANN ARBOR, Mich., Nov. 16, 2022 Esperion today announced that Ben Halladay, MBA, has been promoted to the role of Chief Financial Officer from his prior position of Senior Director, Financial. | November 16, 2022
Ann Arbor-based drug company Esperion Therapeutics Inc. has a new top financial executive. Esperion (NASDAQ: ESPR) promoted Ben Halladay to CFO, it said in a news release late Wednesday. Halladay, 37, who joined Esperion in 2020 and was most recently a senior director of financial planning and…